Huaxia Ophthalmology

What Huaxia Ophthalmology does

Huaxia Ophthalmology Hospital Group (华夏眼科医院集团) is a publicly listed (Shenzhen Stock Exchange: 301267.SZ) Chinese chain of specialized ophthalmology hospitals headquartered in Xiamen, Fujian Province. The group operates 68+ eye hospitals across all major regions of China, anchored by its flagship Xiamen University Affiliated Xiamen Eye Center — a National Clinical Key Specialty and Grade 3A hospital that maintains a sister-center relationship with the Singapore National Eye Centre. Service offerings span the full ophthalmic spectrum through eight subspecialty departments: cataract, refractive surgery, glaucoma, ocular fundus disease, ocular surface and corneal disease, pediatric strabismus/amblyopia, optometry, ocular trauma, and oculoplastic surgery, with additional OK-lens myopia control and RGP/contact lens dispensing.

The group's technology stack centers on premium imported surgical platforms — Zeiss Visumax full-femtosecond laser (SMILE/SMILE Pro refractive surgery), Alcon phaco-vitrectomy systems, NIDEK confocal laser ultra-wide-field fundus imaging, and Lumenis dry-eye OPT — combined with a proprietary Subspecialty Academic Group (学组) system that standardizes clinical protocols across the network. Strategic technology partnerships with Carl Zeiss Meditec and Alcon yield designated premium experience center and treatment base designations. The group also operates an Academician Workstation, National Postdoctoral Research Workstation, and National Resident Training Base, with nationally recognized experts (CAE Academician Xie Lixin, Professors Li Xiaoxin, Zhao Kanxing, Liu Zugu, Ge Jian) anchoring clinical leadership.

Revenue is generated primarily through per-procedure clinical services across self-pay and publicly insured patients (with national cross-region medical insurance settlement supported), supplemented by optical product sales (prescription eyeglasses, OK-lenses, RGP lenses) and specialized diagnostic testing (OCT, fundus angiography, visual field). Pricing varies by region — Lanzhou refractive surgery starts from approximately ¥10,800, OK-lens fittings ¥6,000-¥10,000. Patient acquisition is multi-channel: hospital network presence, a national 24-hour hotline (400-611-2222), online appointment booking, WeChat/Weibo engagement, and charity/public welfare programs (e.g., Tibet Brightness Campaign) that build brand visibility in underserved regions.

Name

Huaxia Ophthalmology

Legal name

华厦眼科医院集团

Website

https://huaxiaeye.com

Company type

Public

Founded year

2016

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Huaxia Ophthalmology is a publicly listed Chinese chain of 68+ specialized ophthalmology hospitals headquartered in Xiamen, offering cataract, refractive, glaucoma, pediatric, and ocular surgery services across all major Chinese regions.

Ownership category

akta.pro rank

Product category

Ophthalmology Hospital Services

NAICS

Offices of Optometrists (62132), Optical Goods Retailers (456130)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ophthalmic Specialty Hospitals (HLAFAHAJ)

akta.pro secondary industries

Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC), Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery) (HLAKAKAO), Comprehensive Eye Exams & Vision Care (HLAKAKAA)

Keywords

• Ophthalmology hospital services
• Refractive surgery
• Cataract treatment
• Pediatric eye care
• Optical products retail

Headquarters

HQ city

Xiamen

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Medical Services: Revenue generated from outpatient consultations, inpatient admissions, and surgical procedures across all specialty departments. Major service lines include cataract surgery, refractive surgery (LASIK, SMILE, ICL), glaucoma treatment, corneal transplantation, retinal procedures, and pediatric ophthalmology. Both self-pay patients and medical insurance (social insurance, urban resident insurance, and national cross-region settlement) are accepted.
2. Optical Products and Optometry Services: Revenue from prescription eyeglasses, contact lenses, orthokeratology lenses (OK镜), RGP lenses, and optometry examination services. Medical optometry centers at each hospital provide refraction, lens fitting, and related products.
3. Medical Examination and Diagnostic Services: Revenue from specialized ophthalmic diagnostic testing including OCT, fundus fluorescein angiography (FFA), visual field testing, corneal topography, IOL measurements, and electrophysiology testing.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Huaxia Ophthalmology operates a national chain of 68+ specialized eye hospitals delivering comprehensive ophthalmic clinical services across nine subspecialty departments (cataract, refractive surgery, glaucoma, ocular surface/cornea, fundus disease, pediatric strabismus/amblyopia, optometry, ocular trauma, oculoplastic surgery) and sells optical products (prescription eyeglasses, contact lenses, orthokeratology/OK lenses, RGP lenses). The group provides advanced surgical procedures including SMILE Pro full-femtosecond laser refractive surgery, ICL crystal implantation, femtosecond laser-assisted cataract surgery, and 25G/27G minimally invasive vitrectomy, supported by national medical insurance settlement and a national 24-hour patient hotline.

Product overview

Huaxia Ophthalmology Hospital Group is a chain of specialized eye hospitals providing comprehensive ophthalmology services across China. The group offers a full spectrum of eye care services through specialized departments including Cataract, Refractive Surgery, Glaucoma, Ocular Fundus Disease, Ocular Surface/Cornea, Pediatric Strabismus/Amblyopia, Optometry, Ocular Trauma, and Ocular Plastic Surgery. The group operates flagship hospitals including Xiamen University Affiliated Eye Center (国家临床重点专科, 三甲眼科) and manages a network of 57+ hospitals across China. Key services include refractive surgery (SMILE Pro, LASIK, ICL), cataract surgery, retinal disease treatment, glaucoma management, and pediatric eye care.

Differentiator

Problem solved

Functional benefit

Brands

• 华厦眼科专家: The group's collective brand for its roster of renowned ophthalmologists, including academicians, professors, and specialists across multiple ophthalmic subspecialties.
• 华厦眼科研究所
• 国家临床重点专科

Products and services

• Cataract Specialty Services (白内障专科) Specialty department offering cataract diagnosis and treatment including phacoemulsification and IOL implantation, femtosecond laser-assisted cataract surgery with navigation, ICL surgery, and infant cataract surgery. B2C - serves patients with cataracts across all ages.
• Refractive Surgery Specialty Services (屈光手术专科) Corneal refractive surgery services for myopia, hyperopia, astigmatism, presbyopia, and corneal diseases, featuring advanced laser equipment including ZEISS Visumax, Ziemer femtosecond lasers, Intralase, and Amaris excimer lasers. Procedures include PRK, LASIK, LASEK, EPI-LASIK, SBK, Trans PRK, P-LASIK, Q-LASIK, K-LASIK, and SMILE Pro. B2C - serves adult patients seeking vision correction.
• Ocular Fundus Disease Specialty Services (眼底病专科) Retinal disease treatment including retinal detachment surgery, genetic eye disease treatment, vitrectomy, diabetic retinopathy treatment, and macular disease treatment. Features 25G/27G minimally invasive vitreous surgery, macular hole surgery, and anti-VEGF drug therapy. B2C - serves patients with retinal and macular conditions.
• Glaucoma Specialty Services (青光眼专科) Glaucoma treatment services including trabeculectomy, combined cataract-glaucoma surgery, glaucoma drainage valve implantation, endoscopic cyclophotocoagulation, and 360° Schlemm's canal surgery. B2C - serves patients with glaucoma.
• Ocular Surface and Corneal Disease Specialty Services (眼表病/角膜病专科) Treatment of dry eye (including Lumenis OPT pulsed light therapy), corneal diseases, and corneal transplantation services. B2C - serves patients with dry eye syndrome, keratoconus, pterygium, corneal ulcers, and those requiring corneal transplantation.
• Pediatric Strabismus and Amblyopia Specialty Services (小儿斜弱视专科) Pediatric eye disease diagnosis and treatment including strabismus surgery, amblyopia treatment, and refractive error screening for children. B2C - serves children and adolescents with strabismus, amblyopia, and pediatric eye conditions.
• Optometry Specialty Services (眼视光专科) Optometry services including prescription eyeglasses, contact lenses, orthokeratology (OK lens) for myopia control, RGP lenses, and refraction/eye examination services. B2C - serves patients requiring vision correction and myopia prevention for children.
• Ocular Trauma Specialty Services (眼外伤专科) Emergency eye trauma services including corneal laceration repair, intraocular foreign body removal, and vitreoretinal surgery. B2C - serves patients with ocular injuries.
• Oculoplastic Specialty Services (眼整形专科) Ocular plastic and cosmetic surgery including blepharoplasty, ptosis correction, and lacrimal disease treatment. B2C - serves patients seeking cosmetic or reconstructive eye procedures.
• ICL Crystal Implantation (ICL晶体植入术) Implantable Collamer Lens (ICL) surgery for high myopia correction. B2C - serves patients with high myopia seeking vision correction.
• Orthokeratology Lenses (OK镜/角膜塑形镜) Ortho-K contact lenses for myopia control and overnight vision correction in children and adolescents. Priced approximately ¥6,000-¥10,000 depending on brand. B2C - serves parents seeking myopia control for children.
• Medical Examination and Diagnostic Services Specialized ophthalmic diagnostic testing including OCT, fundus fluorescein angiography (FFA), visual field testing, corneal topography, IOL measurements, and electrophysiology testing. B2C - serves patients needing advanced eye diagnostics.
• SMILE Pro Astigmatism Correction Enhanced Surgery (新微创全飞秒SMILE pro散光矫正增强版) New minimally invasive all-femtosecond SMILE Pro surgery with enhanced astigmatism correction capability. B2C - serves refractive error patients with astigmatism.

Quantifiable outcome

• 68+ specialized eye hospitals across China with national coverage
• +3 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Xiamen University (厦门大学)coreStrategic or Co-development PartnerXiamen University Affiliated Xiamen Eye Center is the flagship academic medical center of the Huaxia Eye Hospital Group. The partnership enables joint clinical care, academic research, talent cultivation (undergraduate and graduate programs), and provides the academic legitimacy and research infrastructure for the entire network through the Xiamen University Eye Research Institute.
• Singapore National Eye CentrecoreStrategic or Co-development PartnerXiamen University Affiliated Xiamen Eye Center maintains a formal 'sister center' relationship with the Singapore National Eye Centre, enabling international clinical exchange, collaborative research, and knowledge transfer in ophthalmic care.
• Anhui University of Science and Technology (安徽理工大学)minorStrategic or Co-development PartnerAnhui University of Science and Technology jointly established the Anhui University of Science and Technology Affiliated Huainan Eye Hospital with Huaxia Eye Hospital Group and Huainan People's Hospital, creating an integrated眼科医疗、科研、教学 development institution.
• Fudan University Affiliated Eye and ENT Hospital (复旦大学附属眼耳鼻喉科医院)minorStrategic or Co-development PartnerShanghai University Affiliated Shanghai Heping Eye Hospital was co-founded by Fudan University Affiliated Eye and ENT Hospital and Xiamen Eye Center, combining Fudan's academic resources with Huaxia's clinical network.
• National Health Commission定点帮扶 (Government Health Aid Program)minorOthersHuaxia Eye Hospital Group participates in national health poverty alleviation programs, including medical equipment donations to Shaanxi Qingjian County as part of the National Health Commission's定点帮扶 initiative.
• Carl Zeiss Meditec (德国蔡司)coreTechnology or IntegrationHuaxia Eye Group has a strategic technology partnership with Carl Zeiss Meditec, utilizing Zeiss Visumax full-femtosecond laser systems and serving as a designated Zeiss premium experience center, cataract treatment base, and receiving consecutive SMILE surgery awards.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• LV Prasad Eye Institute: A leading Indian specialty eye hospital network with multiple centers offering comprehensive ophthalmology services (cataract, cornea, retina, pediatric) combined with strong academic, research, and public health programs. Comparable to Huaxia in its multi-subspecialty hospital model and social mission focus.
• Aier Eye Hospital Group: The dominant Chinese ophthalmology hospital chain (300015.SZ), operating 800+ eye hospitals across China and globally. Directly comparable to Huaxia in business model (specialty eye hospital chain), service mix (cataract, refractive, glaucoma, pediatric), and target customer segments, but substantially larger in scale.
• Wills Eye Hospital: The oldest and one of the largest US specialty eye hospitals, affiliated with Sidney Kimmel Medical College at Thomas Jefferson University. Comparable to Huaxia as a multi-subspecialty ophthalmology institution with strong academic ties, research output, and premium clinical positioning.
• Singapore National Eye Centre: Singapore's flagship specialty eye hospital and academic center, already a formal sister-center partner of Huaxia's Xiamen Eye Center. Operates as a multi-subspecialty ophthalmology institution serving regional and international patients with strong research and teaching programs.
• Moorfields Eye Hospital NHS Foundation Trust: One of the world's oldest and largest dedicated eye hospitals, based in London. Comparable to Huaxia's flagship Xiamen Eye Center as a multi-subspecialty ophthalmology institution offering cataract, refractive, glaucoma, retinal, and pediatric services with strong academic and research integration.

Others

• Alcon: Global ophthalmic device and pharmaceutical company supplying Huaxia with phaco-vitrectomy systems and participating in dry eye joint development platforms. Comparable as a broad incumbent equipment and pharmaceutical vendor across the ophthalmology ecosystem.
• STAAR Surgical: US-based manufacturer of Implantable Collamer Lenses (ICL) for high myopia correction, a key technology Huaxia uses and promotes. Comparable as an enabling technology vendor and ecosystem participant within the refractive surgery market.
• Carl Zeiss Meditec: German ophthalmic equipment manufacturer and Huaxia's Core technology partner, supplying Visumax full-femtosecond lasers and designating multiple Huaxia hospitals as premium experience centers. Comparable as a key vendor and ecosystem participant, not a direct competitor.

Broad incumbents

• IHH Healthcare: Asia's largest private hospital group operating premium hospitals across Malaysia, Singapore, Turkey, India, and Greater China. Comparable as a multi-country, multi-specialty healthcare provider operating premium facilities with cross-border patient flows, though broader in scope than Huaxia's eye-only focus.
• Topchoice Medical Corporation: A larger diversified Chinese medical group (600763.SH) operating multiple specialty hospitals including dental, orthopedic, and ophthalmology. Less specialized in eye care than Huaxia, but competes in the same Chinese specialty hospital market with broader portfolio and stronger brand.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries57 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Huaxia Ophthalmology